Tianjin Pharmaceutical Da Ren Tang Group Proposes New Independent Director

SGX Filings
Apr 16

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced that its board, at the third meeting for FY2026 held via teleconference on Apr, 16 2026, approved the proposal to appoint Ms. Zhai Shuping as an independent director for a three-year term.

Ms. Zhai, born in Sep, 1975, holds a Doctorate in Economics from Tianjin University of Finance and Economics and is currently a professor and doctoral supervisor at that university’s School of Accounting. She has previously served as an independent director at Tianjin Great Wall Binhai Automotive Finance Co., Ltd. and Jiangsu Gutian Automation Co., Ltd.

The appointment is subject to shareholders’ approval at the company’s upcoming annual general meeting for the financial year ended Dec, 31 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10